Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026)

Pacira BioSciences (PCRX) recorded quarterly Exchange Rate Effect of $38000.0 in Q1 2026, up 109.18% quarter-over-quarter from -$414000.0 in Q4 2025.

Pacira BioSciences (PCRX) Exchange Rate Effect (2025 - 2026) Analysis & Trends

Pacira BioSciences' Exchange Rate Effect history runs 2 years deep, the most recent figure standing at $38000.0 for Q1 2026.

In Q1 2026, Exchange Rate Effect changed N/A year-over-year to $38000.0; the TTM figure through Mar 2026 stood at -$39000.0 (changed N/A YoY), while the FY2025 annual figure was -$77000.0, changed N/A from the prior year.
Exchange Rate Effect was $38000.0 for Q1 2026 at Pacira BioSciences, up from -$414000.0 in the prior quarter.
In the past five years, Exchange Rate Effect ranged from a high of $204000.0 in Q2 2025 to a low of -$414000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FX Effect (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn	-17.00 Mn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn	17.00 Mn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn	-
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn	-
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn	-
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn	-5.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn	-
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn	-22,000.00
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn	-2.38 Mn
10	Pacira BioSciences	935.46 Mn	733.28 Mn	140.96 Mn	38,000.00

Download Data